Medication info
Bavibon Tablets

Bavibon Tablets

Prescription medicationTablet경구
Ingredient · strength
Bazedoxifene Acetate›22.6mg / 1 tabletCholecalciferol Concentrate Powder›8mg / 1 tablet
Manufacturer / importer
현대약품(주)
Appearance
Pink oblong film-coated tablets
Packaging
28 tablets (28 tablets/PTP)
Approval status
Active

MFDS item code 201804005 · Approved 2018.10.11 · Insurance code 642004240

Summary

Main use
Treatment of osteoporosis in postmenopausal women and prevention of spinal fractures
Who takes it
Adults
Adult dose
Take 1 tablet once daily, regardless of meals.

Ingredients

Manufacturer
현대약품(주)

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and prevention of spinal fractures

  • Osteoporosis in postmenopausal women
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women. It is particularly noted for its effectiveness in reducing the occurrence of spinal fractures. However, the efficacy of this medication for non-spinal fractures has not been conclusively demonstrated, and this should be taken into consideration. Overall, it helps improve bone density and reduce the risk of fractures.

How to take

Adult dose

Take 1 tablet once daily, regardless of meals.

Precautions

This medication may increase the risk of venous thromboembolism, which is the formation of blood clots within blood vessels. Conditions such as deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis may occur, therefore it is advisable that women at high risk for thrombosis do not use this medication. This medication is intended for use in postmenopausal women only, and its safety has not been established in premenopausal women; hence it is not recommended for this group. While it does not induce endometrial hyperplasia, if uterine bleeding occurs during the course of treatment, a medical evaluation is mandatory. The safety of this medication has not been established in patients with breast cancer, thus it is advisable not to use it for prevention or treatment of breast cancer. Individuals who have allergies or a history of hypersensitivity to this medication, those with a history of thromboembolism, pregnant women or those who could become pregnant, women who are breastfeeding, individuals with unexplained uterine bleeding, those exhibiting symptoms of endometrial cancer, patients with abnormalities in calcium metabolism, and individuals with certain genetic lactose intolerance should not take this medication. Patients with hypertriglyceridemia, renal or hepatic dysfunction, or those with limited mobility should consult a physician before taking this medication and require careful monitoring during treatment. While taking this medication, side effects such as facial flushing, leg cramps, drowsiness, dry mouth, hives, rash, muscle cramps, peripheral edema, increased blood triglycerides, elevated alanine aminotransferase (ALT), elevated aspartate aminotransferase (AST), vision impairment, blurred vision, photophobia, visual field defects, visual disturbances, dry eyes, eyelid edema, eyelid spasms, eye pain, eye swelling, vomiting, gastritis, belching, leg pain, fatigue, listlessness, and tiredness may occur. If vision problems arise, it is crucial to consult a physician immediately. If calcium intake is inadequate, taking supplements is recommended, and in cases of high risk for vitamin D deficiency, additional vitamin D supplements may be necessary. Caution is required when driving or operating machinery as drowsiness or vision impairments may occur. Pregnant women or those who may become pregnant should not take this medication, and if taken during pregnancy, it should be discontinued immediately, and the physician should be consulted. This medication is not intended for use in children, and while special dosage adjustments are not necessary for the elderly, attention should be paid to any changes in liver function. In cases of overdose, specific antidotes are not available, so treatment should be symptomatic, and symptoms of excessive vitamin D intake may manifest as hypercalcemia; therefore, monitoring calcium levels through blood and urine tests is recommended. This medication should be kept out of reach of children and stored in its original container for safety.

Side effects and when to seek care immediately

Serious side effects

Hives, deep vein thrombosis, pulmonary embolism, retinal vein thrombosis, severe edema, chest tightness, difficulty breathing, allergic reactions, systemic edema, facial swelling, edema accompanied by elevated blood pressure, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, jaundice (yellowing of skin or eyes), severe lethargy, severe allergic reactions, serious neurological symptoms, sudden and severe headache, lightning-like sensation

Mild side effects

Facial flushing, leg cramps, drowsiness, dry mouth, rash, itching, muscle cramps, peripheral edema, elevated blood triglycerides, increased alanine aminotransferase (ALT), increased aspartate aminotransferase (AST), vision impairment, blurred vision, photophobia, visual field defects, visual disturbances, dry eyes, eyelid edema, eyelid spasms, eye pain, eye swelling, vomiting, gastritis, belching, leg pain, fatigue, listlessness, tiredness,

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1°C and 30°C to preserve its efficacy over time.

Appearance and packaging

Appearance

Pink oblong film-coated tablets

Package unit

28 tablets (28 tablets/PTP)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.